B
Beacon Biomedical
Easy, Accurate & Affordable Cancer Screening
About Beacon Biomedical
Beacon Biomedical Inc. is a medical diagnostic development company and a Centers of Medicare and Medicaid Services (CMS) CLIA accredited laboratory services provider. The company focuses on creating easy, accurate, and affordable blood tests for early cancer detection. Their primary product, BeScreened CRC, is a blood-based test designed to help primary care providers screen patients for colorectal cancer, particularly those who are unwilling or unable to use traditional screening methods like colonoscopies. Beacon Biomedical operates in the healthcare diagnostics market, serving primary care providers and patients who need non-invasive cancer screening options. The company's business model revolves around developing laboratory-developed tests (LDTs) and offering them to healthcare practitioners and individuals. Revenue is generated through the sale of these diagnostic tests and related laboratory services.
Source: Dealroom company dataAt a glance
- Founded
- 2014
- Headquarters
- Phoenix, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
US Department of Health and Human Services
Series A2 investors entered at this stage
Pacific investment Management
Centana Growth Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Beacon Biomedical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Beacon Biomedical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.